Rajesh Krishnamurthy1, Mark C Manning
1Human Genome Sciences, Inc., Rockville, MD, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Developing stable protein pharmaceuticals requires understanding degradation pathways like denaturation, aggregation, oxidation, and interfacial damage. This knowledge is crucial for effective formulation strategies and preventing decomposition.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: